MNKD (MannKind Corporation) חוב לטווח קצר להון
MannKind Corporation (MNKD) operates its own US-based manufacturing facility to produce innovative drug delivery systems and inhalers. The business monetizes its unique Technosphere platform through licensing agreements with industry behemoths and the development of orphan drugs. This price chart featuring the 0.00 indicator confirms growth potential amid rising demand for convenient therapies for diabetes and pulmonary pathologies.
פילוחים אנליטיים של חברת MannKind Corporation
For MannKind Corporation (MNKD), the current short-term debt-to-equity chart reflects the dependence of inhaler supplies on operational liquidity amid geopolitical instability and logistics disruptions. The ratio of liabilities maturing within one year to equity measures the risk of excessive reliance on "fast" leverage, allowing investors to assess the resilience of the company's balance sheet to a sudden contraction of sales markets.